Genetheraptics Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.91 M
- Revenue Growth 0.31%
- Profit Growth 1.90%
- Ebitda -30.71%
- Net Worth 20.88%
- Total Assets 22.38%
About Genetheraptics Pharma
Genetheraptics Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 November 2017 (Seven years and two months 30 days old ). Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹7.91 M.
Sekhar Mandava and Sujitha Mandava serve as directors at the Company.
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999AP2017PTC107118
- Company No.
107118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
What products or services does Genetheraptics Pharma Private Limited offer?
Genetheraptics Pharma Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Disinfectant Chemicals, Bird Food, Poultry & Animal Food, Fish Foods, Animal Feed Supplement, Material Testing Labs & Services, Chemical Testing Services, Feed Additives.
Who are the key members and board of directors at Genetheraptics Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekhar Mandava  | Director | 27-Nov-2017 | Current |
| Sujitha Mandava | Director | 27-Nov-2017 | Current |
Financial Performance of Genetheraptics Pharma.
Genetheraptics Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.31% increase. The company also saw a slight improvement in profitability, with a 1.9% increase in profit. The company's net worth Soared by an impressive increase of 20.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genetheraptics Pharma?
Unlock access to Genetheraptics Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Glyco Bio Pharma Private LimitedSekhar Mandava and Sujitha Mandava are mutual person
Charges (Loans)
₹7.91 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2020 | Indian Bank | ₹7.91 M | Open |
How Many Employees Work at Genetheraptics Pharma?
Genetheraptics Pharma has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetheraptics Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetheraptics Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.